Skip to Content

Press Releases

Congressman Arrington Reintroduces the Access to Future Cures Act

WASHINGTON, D.C. – Today, Representative Jodey Arrington (TX-19) joined Rep. Kevin Hern (OK-01) and Rep. Jimmy Panetta (CA-19) to reintroduce the Access to Future Cures Act, legislation to allow American families to use pre-tax money to pay for preventative blood storage services.

Preserved healthy blood cells can be used to develop cell-and-gene-based therapies to address various conditions and illnesses, such as cardiovascular disease, diabetes, macular degeneration, and Parkinson’s disease. The Access to Future Cures Act will allow individuals to use their Health Savings Account (HSA), Health Reimbursement Arrangement (HRA), and Flexible Spending Arrangement (FSA) to store healthy blood cells and prepare for the potential need for cell-and-gene-based therapies.

“Blood storage technology is yet another example of American ingenuity at the cutting edge of medical science, one that can have fundamental positive impacts on future health outcomes,” said Rep. Arrington. “This bill will empower American families to take preventative healthcare measures into their own hands using their pre-tax dollars.”

We’ve made incredible breakthroughs in cell and gene-based therapies, which have the potential to treat long-term illnesses as varied as COVID-19, bloodborne cancers, Alzheimer’s, type 1 diabetes, and more.  The cost of extracting and storing healthy blood cells should not be a barrier to this groundbreaking care,” said Rep. Panetta. “I’m proud to co-lead this bipartisan solution with Chairman Arrington so that more Americans with health savings accounts can access these therapies and better care in the future.”